Sam Brusco, Associate Editor11.30.21
ImmersiveTouch announced during RSNA 2021 that it achieved FDA 510(k) clearance for its modular software package to import, visualize, and automatically segment medical images to create accurate 3D representations.
The segmented 3D models can be used for diagnosis, anatomical measuring, treatment planning, and creating output files for additive manufacturing. The technology has been used to generate virtual reality surgical plans used in over 900 procedures this year, and is deployed in almost 70 high-ranking hospitals.
Dr. Matthew Ranzer, M.D. of plastic surgery at Mount Sinai Hospital told the press, “One of the things that I like about ImmersiveTouch is that it’s not expensive, but it adds value to our system. The ability to simulate these surgical procedures in fine detail, makes our operations more efficient and safer for our patients and provides a real benefit to our hospital and community.”
According to Facts and Factors, the market size for Virtual Reality in Healthcare is expected to grow by a CAGR of 34.89 percent to $40.98 billion by 2026, up from $2.70 billion in 2020.
“As the healthcare industry really starts to embrace technological advancements, we are able to help reduce surgical planning and operative times, improving surgical efficiency and minimizing workflow disruptions,” said Pat Banerjee, CEO of ImmersiveTouch.
ImmersiveTouch’s COO Jay Banerjee said, “adding this additional FDA 510(k) Clearance for medical diagnosis and treatment planning to our portfolio just strengthens what ImmersiveTouch can offer surgeons.”
The segmented 3D models can be used for diagnosis, anatomical measuring, treatment planning, and creating output files for additive manufacturing. The technology has been used to generate virtual reality surgical plans used in over 900 procedures this year, and is deployed in almost 70 high-ranking hospitals.
Dr. Matthew Ranzer, M.D. of plastic surgery at Mount Sinai Hospital told the press, “One of the things that I like about ImmersiveTouch is that it’s not expensive, but it adds value to our system. The ability to simulate these surgical procedures in fine detail, makes our operations more efficient and safer for our patients and provides a real benefit to our hospital and community.”
According to Facts and Factors, the market size for Virtual Reality in Healthcare is expected to grow by a CAGR of 34.89 percent to $40.98 billion by 2026, up from $2.70 billion in 2020.
“As the healthcare industry really starts to embrace technological advancements, we are able to help reduce surgical planning and operative times, improving surgical efficiency and minimizing workflow disruptions,” said Pat Banerjee, CEO of ImmersiveTouch.
ImmersiveTouch’s COO Jay Banerjee said, “adding this additional FDA 510(k) Clearance for medical diagnosis and treatment planning to our portfolio just strengthens what ImmersiveTouch can offer surgeons.”